'Blue-sky' oyster vaccine has global potential say scientists

'Blue-sky' oyster vaccine has global potential say scientists
The Pacific oyster industry has struggled with a deadly virus since 2010. (Image: Moana NZ)
Greg Hurrell
The newest research into fighting a virus that devastated New Zealand’s multimillion-dollar Pacific oyster industry has global commercial potential despite its novel and “blue-sky nature”, scientists say.Nelson's independent Cawthron Institute has been granted $1 million over three years from the Endeavour Fund to develop a practical vaccine for Pacific oyster mortality syndrome (Poms), a goal previously thought impossible for shellfish.The Ministry of Business, Innovation and Employment (MBIE) administers the fund.The gra...

More Primary Sector

Pāmu lifts guidance as milk price, production rises
Primary Sector

Pāmu lifts guidance as milk price, production rises

State-owned farm operator now expects profit of between $25m and $40m.

Riley Kennedy 22 Nov 2024
Waiū Dairy still backed despite write-down
Primary Sector

Waiū Dairy still backed despite write-down

Māori Investments among Kawerau processor's largest shareholders.

Riley Kennedy 22 Nov 2024
Zespri raises profit guidance, fruit forecasts
Primary Sector

Zespri raises profit guidance, fruit forecasts

Growers are voting on expanding the co-op's overseas supply.

Riley Kennedy 21 Nov 2024